Ligands to the (IRAP)/AT4 receptor encompassing a 4-hydroxydiphenylmethane scaffold replacing Tyr2

Bioorganic and Medicinal Chemistry

Volumn 16, Issue 14, 2008, Pages 6924-6935

  Andersson, Hanna ^a   Demaegdt, Heidi ^b   Vauquelin, Georges ^b   Lindeberg, Gunnar ^a   Karlén, Anders ^a   Hallberg, Mathias ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

4 Hydroxydiphenylmethane; Aminopeptidase N (AP N); Angiotensin IV; Cystinyl aminopeptidase (CAP); Insulin regulated aminopeptidase (IRAP); Peptide mimetic; Peptide synthesis; Structure activity relationship; Tyrosine mimetic

Indexed keywords

4 BENZYLPHENOL; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN II [3-8]; ANGIOTENSIN II [3-8] DERIVATIVE; ANGIOTENSIN RECEPTOR; BENZOIC ACID; CYSTYL AMINOPEPTIDASE; HISTIDINE; METHANE; MICROSOMAL AMINOPEPTIDASE; PHENYLACETIC ACID; PHENYLALANINE; PROLINE; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BIOASSAY; CONTROLLED STUDY; CYCLIZATION; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN DEGRADATION; STRUCTURE ACTIVITY RELATION;

ANGIOTENSIN II; ANIMALS; BENZHYDRYL COMPOUNDS; CRICETINAE; CYSTINYL AMINOPEPTIDASE; LIGANDS; PEPTIDES; RECEPTORS, ANGIOTENSIN; TYROSINE;

EID: 47349126657     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2008.05.046     Document Type: Article

References (60)

1. Hallberg M., Le Greves P., and Nyberg F. Neuropeptide processing. Proteases in Biology and Disease. Proteases in the Brain (2005), Springer Science, New York 203-234
2. Hallberg M., and Nyberg F. Curr. Protein Pept. Sci. 4 (2003) 31-44
3. Chai S.Y., Fernando R., Peck G., Ye S.Y., Mendelsohn F.A., Jenkins T.A., and Albiston A.L. Cell. Mol. Life Sci. 61 (2004) 2728-2737
4. Vauquelin G., Michotte Y., Smolders I., Sarre S., Ebinger G., Dupont A., and Vanderheyden P. J. Renin Angiotensin Aldosterone Syst. 3 (2002) 195-204
5. von Bohlen und Halbach O. Cell Tissue Res. 311 (2003) 1-9
6. de Gasparo M., Husain A., Alexander W., Catt K.J., Chiu A.T., Drew M., Goodfriend T., Harding J.W., Inagami T., and Timmermans P.B.M.W.M. Hypertension 25 (1995) 924-927
7. de Gasparo M., Catt K.J., Inagami T., Wright J.W., and Unger T. Pharmacol. Rev. 52 (2000) 415-472
8. Swanson G.N., Hanesworth J.M., Sardinia M.F., Coleman J.K., Wright J.W., Hall K.L., Miller-Wing A.V., Stobb J.W., Cook V.I., Harding E.C., et al. Regul. Pept. 40 (1992) 409-419
9. Rogi T., Tsujimoto M., Nakazato H., Mizutani S., and Tomoda Y. J. Biol. Chem. 271 (1996) 56-61
10. Albiston A.L., McDowall S.G., Matsacos D., Sim P., Clune E., Mustafa T., Lee J., Mendelsohn F.A., Simpson R.J., Connolly L.M., and Chai S.Y. J. Biol. Chem. 276 (2001) 48623-48626
11. Braszko J.J., Kupryszewski G., Witczuk B., and Wisniewski K. Neuroscience 27 (1988) 777-783
12. Delorenzi A., Locatelli F., Romano A., Nahmod V., and Maldonado H. Neurosci. Lett. 226 (1997) 143-146
13. Delorenzi A., and Maldonado H. Neurosci. Lett. 266 (1999) 1-4
14. Lee J., Albiston A.L., Allen A.M., Mendelsohn F.A., Ping S.E., Barrett G.L., Murphy M., Morris M.J., McDowall S.G., and Chai S.Y. Neuroscience 124 (2004) 341-349
15. Olson M.L., Olson E.A., Qualls J.H., Stratton J.J., Harding J.W., and Wright J.W. Peptides 25 (2004) 233-241
16. Pederson E.S., Harding J.W., and Wright J.W. Regul. Pept. 74 (1998) 97-103
17. Wright J.W., Miller-Wing A.V., Shaffer M.J., Higginson C., Wright D.E., Hanesworth J.M., and Harding J.W. Brain Res. Bull. 32 (1993) 497-502
18. Wright J.W., Stubley L., Pederson E.S., Kramar E.A., Hanesworth J.M., and Harding J.W. J. Neurosci. 19 (1999) 3952-3961
19. Miller-Wing A.V., Hanesworth J.M., Sardinia M.F., Hall K.L., Wright J.W., Speth R.C., Grove K.L., and Harding J.W. J. Pharmacol. Exp. Ther. 266 (1993) 1718-1726
20. Roberts K.A., Krebs L.T., Kramar E.A., Shaffer M.J., Harding J.W., and Wright J.W. Brain Res. 682 (1995) 13-21
21. Wright J.W., Krebs L.T., Stobb J.W., and Harding J.W. Front. Neuroendocrinol. 16 (1995) 23-52
22. Fernando R.N., Larm J., Albiston A.L., and Chai S.Y. J. Comp. Neurol. 487 (2005) 372-390
23. Keller S.R., Scott H.M., Mastick C.C., Aebersold R., and Lienhard G.E. J. Biol. Chem. 270 (1995) 23612-23618
24. Lew R.A., Mustafa T., Ye S., McDowall S.G., Chai S.Y., and Albiston A.L. J. Neurochem. 86 (2003) 344-350
25. Albiston A.L., Mustafa T., McDowall S.G., Mendelsohn F.A., Lee J., and Chai S.Y. Trends Endocrinol. Metab. 14 (2003) 72-77
26. Wallis M.G., Lankford M.F., and Keller S.R. Am. J. Physiol. Endocrinol. Metab. (2007)
27. Wright J.W., and Harding J.W. Prog. Neurobiol. 72 (2004) 263-293
28. Garreau I., Chansel D., Vandermeersch S., Fruitier I., Piot J.M., and Ardaillou R. Peptides 19 (1998) 1339-1348
29. Demaegdt H., Lenaerts P.J., Swales J., De Backer J.P., Laeremans H., Le M.T., Kersemans K., Vogel L.K., Michotte Y., Vanderheyden P., and Vauquelin G. Eur. J. Pharmacol. 546 (2006) 19-27
30. Braszko J.J. Physiol. Behav. 88 (2006) 152-159
31. Lee J., Chai S.Y., Mendelsohn F.A., Morris M.J., and Allen A.M. Neuropharmacology 40 (2001) 618-623
32. Ariano M.A., Fisher R.S., Smyk-Randall E., Sibley D.R., and Levine M.S. Brain Res. 609 (1993) 71-80
33. von Bohlen und Halbach O., and Albrecht D. Neuroendocrinology 72 (2000) 218-223
34. Wright J.W., and Harding J.W. Brain Res. Brain Res. Rev. 25 (1997) 96-124
35. Stragier B., Demaegdt H., De Bundel D., Smolders I., Sarre S., Vauquelin G., Ebinger G., Michotte Y., and Vanderheyden P. Brain Res. 1131 (2007) 97-105
36. Georgsson J., Skold C., Plouffe B., Lindeberg G., Botros M., Larhed M., Nyberg F., Gallo-Payet N., Gogoll A., Karlen A., and Hallberg A. J. Med. Chem. 48 (2005) 6620-6631
37. Tang Z.L., and Pelletier J.C. Tetrahedron Lett. 39 (1998) 4773-4776
38. Xu J., and Guo Z. Carbohydr. Res. 337 (2002) 87-91
39. Negishi E.-i., Bagheri V., Chatterjee S., Luo F.-T., Miller J.A., and Stoll A.T. Tetrahedron Lett. 24 (1983) 5181-5184
40. In: Negishi E.-i. (Ed). Handbook of Organopalladium Chemistry for Organic Synthesis Vol. 1 (2002), Wiley-Interscience, New York
41. Chaumel F., and Beland F. Abstr. Papers Am. Chem. Soc. 224 (2002) U184
42. Wada T., Ohkubo A., Mochizuki A., and Sekine M. Tetrahedron Lett. 42 (2001) 1069-1072
43. Togo H., and Hirai T. Synlett (2003) 702-704
44. Amijs C.H.M., van Klink G.P.M., and van Koten G. Green Chem. 5 (2003) 470-474
45. Axén A., Andersson H., Lindeberg G., Ronnholm H., Kortesmaa J., Demaegdt H., Vauquelin G., Karlen A., and Hallberg M. J. Pept. Sci. 13 (2007) 434-444
46. Barlos K., Gatos D., Kallitsis J., Papaphotiu G., Sotiriu P., Yao W.Q., and Schafer W. Tetrahedron Lett. 30 (1989) 3943-3946
47. Hruby V.J. Nat. Rev. Drug Discov. 1 (2002) 847-858
48. Hruby V.J., and Balse P.M. Curr. Med. Chem. 7 (2000) 945-970
49. Axén A., Lindeberg G., Demaegdt H., Vauquelin G., Karlén A., and Hallberg M. J. Pept. Sci. 12 (2006) 705-713
50. Patchett A.A., and Nargund R.P. Annu. Rep. Med. Chem. 35 (2000) 289-298
51. Sardinia M.F., Hanesworth J.M., Krishnan F., and Harding J.W. Peptides 15 (1994) 1399-1406
52. Kobori, T.; Goda, K.; Sugimoto, K.; Ota, T.; Tomisawa, K. Preparation of amino acid derivatives as angiotensin IV receptor agonists. WO 98/05624 A1, 1998.
53. Sardinia M.F., Hanesworth J.M., Krebs L.T., and Harding J.W. Peptides 14 (1993) 949-954
54. Krishnan R., Hanesworth J.M., Wright J.W., and Harding J.W. Peptides 20 (1999) 915-920
55. Lahoutte T., Mertens J., Caveliers V., Franken P.R., and Everaert H. J. Nucl. Med. 44 (2003) 1489-1494
56. Johansen T.E., Scholler M.S., Tolstoy S., and Schwartz T.W. FEBS Lett. 267 (1990) 289-294
57. Olsen J., Cowell G.M., Konigshofer E., Danielsen E.M., Moller J., Laustsen L., Hansen O.C., Welinder K.G., Engberg J., Hunziker W., Spiess M., Sjostrom H., and Noren O. FEBS Lett. 238 (1988) 307-314
58. Le M.T., De Backer J.P., Hunyady L., Vanderheyden P.M., and Vauquelin G. Eur. J. Pharmacol. 513 (2005) 35-45
59. Demaegdt H., Vanderheyden P., De Backer J.P., Mosselmans S., Laeremans H., Le M.T., Kersemans V., Michotte Y., and Vauquelin G. Biochem. Pharmacol. 68 (2004) 885-892
60. Cheng Y., and Prusoff W.H. Biochem. Pharmacol. 22 (1973) 3099-3108